Freestone Grove Partners LP

Position in PFE — Pfizer Inc

CIK 2007591 San Francisco, CA

Position in PFE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,079,562

+$5,808,284 QoQ

Shares Held

335,530

+314.8% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#467

of 2,821 holders

Holding Since

Dec 2024

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Freestone Grove Partners LP holds $182,044,995 across 6 Drug Manufacturers - General names. PFE ranks #4 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	517,230	$131,360,903
2	BIIB	Biogen Inc.	83,853	$18,117,279
3	LLY	ELI LILLY & Co	13,442	$16,122,739
4	PFE	Pfizer Inc This page	335,530	$8,079,562
5	BMY	Bristol Myers Squibb Co	84,601	$4,874,709
6	MRK	Merck & Co., Inc.	27,158	$3,489,803

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,079,562	335,530	+314.8%	Shares	Sole	2026-08-14
2026-03-31	$2,271,278	80,886	-92.3%	Shares	Sole	2026-05-15
2025-12-31	$26,142,036	1,049,881	+3255.6%	Shares	Sole	2026-02-17
2025-03-31	$792,812	31,287	+72.5%	Shares	Sole	2025-05-15
2024-12-31	$481,095	18,134	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.